title: Treatment of acquired aplastic anemia in children.
abstract: Aplastic anemia (AA) is an uncommon but serious disorder characterized by pancytopenia resulting from non-function of the bone marrow. The incidence of AA is approximately 3 fold more common in East Asia than in Europe and United States where yearly incidence rates  are approximately two patients per one million.
authors.affiliation: Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan. kojimas@med.nagoya-u.ac.jp
authors.forename: Seiji
authors.initials: S
authors.lastname: Kojima
mesh_terms: D000293:Adolescent; D000741:Anemia, Aplastic / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy*; D016026:Bone Marrow Transplantation / Q000379:methods; D002648:Child; D002675:Child, Preschool; D005060:Europe; D005202:Asia, Eastern; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D033581:Stem Cell Transplantation / Q000379:methods; D014481:United States
chemical_list: D007166:Immunosuppressive Agents